Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 0 29 0 0 1 134
Aging and the Growth of Long-Term Care 0 0 0 242 0 0 1 1,286
An Economic Evaluation of the War on Cancer 0 0 1 96 0 0 3 355
Are the Young Becoming More Disabled? 0 0 0 93 0 0 0 344
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 0 152 0 0 3 540
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 67 0 1 2 376
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 0 1 35
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 0 0 2 33
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 1 55 9 16 44 237
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 5 0 1 3 30
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 1 6 0 1 3 50
Evaluation of Medical Technologies with Uncertain Benefits 0 0 0 48 0 0 3 41
Food Prices and the Dynamics of Body Weight 0 0 0 70 0 0 2 229
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 4 5 633
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 0 13 0 0 1 50
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 0 0 1 421
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 0 0 1 189
Insurance and Innovation in Health Care Markets 0 0 0 136 0 0 0 465
Insurance, Self-Protection, and the Economics of Terrorism 0 0 0 287 0 0 0 884
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 0 32 0 0 3 145
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 0 0 95
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 0 0 0 69
Intellectual Property and Marketing 0 0 0 91 0 0 5 384
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 0 0 122
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 2 2 4 261
International Differences in Longevity and Health and their Economic Consequences 0 0 0 54 0 0 0 167
Mortality Risk, Insurance, and the Value of Life 0 0 1 37 1 1 5 43
Nonprofit Production 0 0 0 0 0 0 2 195
Nonprofit Production and Competition 2 2 3 296 2 3 7 1,236
Optimal Liability for Terrorism 0 0 0 40 0 0 2 211
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 1 22 1 5 11 89
The Declining Quality of Teachers 0 0 1 221 0 1 5 1,670
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 4 490 0 1 17 1,594
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 88 0 0 4 364
The Insurance Value of Medical Innovation 0 0 1 31 0 0 2 95
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 233 0 1 2 1,767
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 1 29 0 2 5 161
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 0 1 3 462
The Welfare Effects of Public Drug Insurance 0 0 0 77 0 0 0 284
Time-Inconsistency and Welfare 0 0 0 78 0 2 4 371
Understanding Health Disparities Across Education Groups 0 0 0 390 0 0 4 1,681
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 42 0 0 0 222
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 0 0 111
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 0 0 0 177
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 2 3 10 96
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data 0 0 2 2 0 0 9 13
Total Working Papers 2 2 18 4,198 17 45 180 18,417


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 0 0 1 56 0 0 3 213
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 0 0 0 2 1 1 3 17
A Theory of Health Disparities and Medical Technology 0 1 4 130 4 11 39 566
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) 0 0 1 1 0 1 10 10
An economic evaluation of the war on cancer 0 0 3 104 2 7 26 557
Are Biopharmaceutical Budget Caps Good Public Policy? 0 0 0 12 0 0 0 72
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 0 11 0 0 1 77
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 0 1 35 1 1 2 178
Can the ACA Improve Population Health? 0 0 0 13 0 0 0 63
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 0 0 14 0 1 3 96
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 1 1 1 26 1 1 3 101
Disability Forecasts and Future Medicare Costs 1 1 1 34 1 2 2 269
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 1 1 1 40 2 2 5 166
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 0 0 1 15
Does Medicare benefit the poor? 1 2 5 129 1 2 10 317
Economics of the Pharmaceutical Industry 5 9 44 276 12 22 101 630
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 0 0 20
Geographic Variation in Health Care: The Role of Private Markets 0 0 1 73 4 7 29 394
HIV Breakthroughs and Risky Sexual Behavior 0 0 4 164 0 1 8 902
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 0 15 0 0 0 281
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 0 0 7 94 0 2 15 297
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 0 0 8 64
Health insurance as a two-part pricing contract 0 0 3 48 0 1 7 354
Health technology assessment with risk aversion in health 0 0 1 6 0 1 4 32
Innovation and the welfare effects of public drug insurance 0 0 0 41 1 1 2 148
Insurance, self-protection, and the economics of terrorism 0 1 2 77 0 3 9 307
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 1 2 16 0 2 5 130
Is nursing home demand affected by the decline in age difference between spouses? 0 0 0 26 0 0 2 323
Labor Supply and Weight 1 1 3 44 1 1 5 122
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 0 45 0 0 4 174
Pharmaceutical advertising and Medicare Part D 0 0 0 12 0 1 1 144
Predicting quantity and quality of life with the Future Elderly Model 0 0 2 2 0 1 7 8
Public Financing and the Market for Long-Term Care 0 0 0 24 0 0 0 97
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 1 14 0 0 4 90
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 0 38 0 0 2 136
Social insurance and the design of innovation incentives 0 0 0 20 1 1 1 85
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 1 1 68 0 3 7 287
The Economics of Teacher Quality 0 0 0 6 1 4 6 205
The Fiscal Consequences of Trends in Population Health 0 0 1 13 1 1 3 61
The Labor Market Value of Health Improvements 0 0 0 44 0 0 1 151
The Rise in Old-Age Longevity and the Market for Long-Term Care 0 0 1 106 0 1 7 434
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population 0 0 1 2 0 0 7 19
The Value of Diagnostic Testing in Personalized Medicine 0 1 4 58 1 2 11 214
The economics of alternative payment models for pharmaceuticals 0 1 3 7 2 4 12 30
The growth of obesity and technological change 0 0 1 29 1 1 4 118
The insurance value of medical innovation 0 0 1 31 0 4 13 144
The nonprofit sector and industry performance 0 1 6 241 0 3 12 674
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 1 1 4 0 2 5 41
The value of medical and pharmaceutical interventions for reducing obesity 0 0 1 15 0 0 3 93
The welfare effects of medical malpractice liability 0 0 0 14 0 1 2 133
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market* 0 0 0 0 0 0 1 2
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 0 0 0 100
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 0 0 0 4 11
Welfare-Enhancing Technological Change and the Growth of Obesity 0 2 2 150 0 4 5 422
Total Journal Articles 10 25 111 2,464 38 103 425 10,594


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 0 1 2 23 1 2 4 105
Economics of Obesity 0 0 0 22 0 0 1 80
Economics of Obesity 0 0 2 34 0 0 3 87
Food Prices and the Dynamics of Body Weight 0 0 1 14 0 0 2 68
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 0 6 88 0 0 12 223
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 0 1 61
Public Financing and the Market for Long-Term Care 0 0 0 8 0 0 0 49
Total Chapters 0 1 11 201 1 2 23 673


Statistics updated 2023-03-10